CoChat

Myeloid cells in Alzheimer’s disease: culprits, victims or innocent bystanders?

Meyer-Luehmann, Melanie, Prinz, Marco · 2015 · Trends in Neurosciences
Cited by 55

The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.tins.2015.08.011

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 68 references

Research works printed but not linked: 46

  1. Geissmann, 2010, Unravelling mononuclear phagocyte heterogeneity, Nat. Rev. Immunol., 10, 453, 10.1038/nri2784 · DOI · Paper page
  2. Yona, 2013, Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis, Immunity, 38, 79, 10.1016/j.immuni.2012.12.001 · DOI · Paper page
  3. Ginhoux, 2010, Fate mapping analysis reveals that adult microglia derive from primitive macrophages, Science, 330, 841, 10.1126/science.1194637 · DOI · Paper page
  4. Schulz, 2012, A lineage of myeloid cells independent of Myb and hematopoietic stem cells, Science, 336, 86, 10.1126/science.1219179 · DOI · Paper page
  5. Hagan, 2015, The molecular, cellular, and morphological components of blood-brain barrier development during embryogenesis, Semin. Cell Dev. Biol., 38, 7, 10.1016/j.semcdb.2014.12.006 · DOI
  6. Biber, 2015, CNS myeloid cells as drug targets: current status and translational challenges, Nat. Rev. Drug Discov.
  7. Hanisch, 2007, Microglia: active sensor and versatile effector cells in the normal and pathologic brain, Nat. Neurosci., 10, 1387, 10.1038/nn1997 · DOI · Paper page
  8. Jung, 2000, Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion, Mol. Cell. Biol., 20, 4106, 10.1128/MCB.20.11.4106-4114.2000 · DOI · Paper page
  9. Nimmerjahn, 2005, Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo, Science, 308, 1314, 10.1126/science.1110647 · DOI · Paper page
  10. Davalos, 2005, ATP mediates rapid microglial response to local brain injury in vivo, Nat. Neurosci., 8, 752, 10.1038/nn1472 · DOI · Paper page
  11. Erny, 2015, Host microbiota constantly control maturation and function of microglia in the CNS, Nat. Neurosci., 18, 965, 10.1038/nn.4030 · DOI · Paper page
  12. McMahon, 2006, CNS dendritic cells: critical participants in CNS inflammation?, Neurochem. Int., 49, 195, 10.1016/j.neuint.2006.04.004 · DOI
  13. D’Agostino, 2012, Brain dendritic cells: biology and pathology, Acta Neuropathol., 124, 599, 10.1007/s00401-012-1018-0 · DOI · Paper page
  14. Barkauskas, 2013, Extravascular CX3CR1+ cells extend intravascular dendritic processes into intact central nervous system vessel lumen, Microsc. Microanal., 19, 778, 10.1017/S1431927613000482 · DOI · Paper page
  15. Haass, 2004, Take five – BACE and the gamma-secretase quartet conduct Alzheimer's amyloid beta-peptide generation, EMBO J., 23, 483, 10.1038/sj.emboj.7600061 · DOI · Paper page
  16. Haass, 2007, Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide, Nat. Rev. Mol. Cell Biol., 8, 101, 10.1038/nrm2101 · DOI · Paper page
  17. Yan, 2006, Abeta42 is more rigid than Abeta40 at the C terminus: implications for Abeta aggregation and toxicity, J. Mol. Biol., 364, 853, 10.1016/j.jmb.2006.09.046 · DOI · Paper page
  18. Frautschy, 1998, Microglial response to amyloid plaques in APPsw transgenic mice, Am. J. Pathol., 152, 307
  19. Paresce, 1997, Slow degradation of aggregates of the Alzheimer's disease amyloid beta-protein by microglial cells, J. Biol. Chem., 272, 29390, 10.1074/jbc.272.46.29390 · DOI · Paper page
  20. Majumdar, 2008, Degradation of fibrillar forms of Alzheimer's amyloid beta-peptide by macrophages, Neurobiol. Aging, 29, 707, 10.1016/j.neurobiolaging.2006.12.001 · DOI
  21. Wisniewski, 1991, Phagocytosis of beta/A4 amyloid fibrils of the neuritic neocortical plaques, Acta Neuropathol., 81, 588, 10.1007/BF00310142 · DOI
  22. Akiyama, 1996, The amino-terminally truncated forms of amyloid beta-protein in brain macrophages in the ischemic lesions of Alzheimer's disease patients, Neurosci. Lett., 219, 115, 10.1016/S0304-3940(96)13197-9 · DOI
  23. Brawek, 2014, Impairment of in vivo calcium signaling in amyloid plaque-associated microglia, Acta Neuropathol., 127, 495, 10.1007/s00401-013-1242-2 · DOI
  24. Wilcock, 2001, Number of Abeta inoculations in APP+PS1 transgenic mice influences antibody titers, microglial activation, and congophilic plaque levels, DNA Cell Biol., 20, 731, 10.1089/10445490152717596 · DOI · Paper page
  25. Wilcock, 2004, Passive amyloid immunotherapy clears amyloid and transiently activates microglia in a transgenic mouse model of amyloid deposition, J. Neurosci., 24, 6144, 10.1523/JNEUROSCI.1090-04.2004 · DOI · Paper page
  26. Noda, 2011, Fractalkine attenuates excito-neurotoxicity via microglial clearance of damaged neurons and antioxidant enzyme heme oxygenase-1 expression, J. Biol. Chem., 286, 2308, 10.1074/jbc.M110.169839 · DOI · Paper page
  27. Ye, 2015, Progression of seed-induced Abeta deposition within the limbic connectome, Brain Pathol., 10.1111/bpa.12252 · DOI · Paper page
  28. Guerreiro, 2013, TREM2 variants in Alzheimer's disease, N. Engl. J. Med., 368, 117, 10.1056/NEJMoa1211851 · DOI · Paper page
  29. Patel, 2005, Inflammatory cytokine levels correlate with amyloid load in transgenic mouse models of Alzheimer's disease, J. Neuroinflammation, 2, 9, 10.1186/1742-2094-2-9 · DOI · Paper page
  30. Lue, 2001, Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro, Glia, 35, 72, 10.1002/glia.1072 · DOI · Paper page
  31. Cacabelos, 1991, Cerebrospinal fluid interleukin-1 beta (IL-1 beta) in Alzheimer's disease and neurological disorders, Methods Find. Exp. Clin. Pharmacol., 13, 455
  32. Tachida, 2008, Interleukin-1 beta up-regulates TACE to enhance alpha-cleavage of APP in neurons: resulting decrease in Abeta production, J. Neurochem., 104, 1387, 10.1111/j.1471-4159.2007.05127.x · DOI · Paper page
  33. Akiyama, 2000, Inflammation and Alzheimer's disease, Neurobiol. Aging, 21, 383, 10.1016/S0197-4580(00)00124-X · DOI · Paper page
  34. Alafuzoff, 1983, Albumin and immunoglobulin in plasma and cerebrospinal fluid, and blood-cerebrospinal fluid barrier function in patients with dementia of Alzheimer type and multi-infarct dementia, J. Neurol. Sci., 60, 465, 10.1016/0022-510X(83)90157-0 · DOI
  35. Elovaara, 1985, CSF in Alzheimer's disease. Studies on blood–brain barrier function and intrathecal protein synthesis, J. Neurol. Sci., 70, 73, 10.1016/0022-510X(85)90189-3 · DOI
  36. Hampel, 1997, Blood-cerebrospinal fluid barrier dysfunction for high molecular weight proteins in Alzheimer disease and major depression: indication for disease subsets, Alzheimer Dis. Assoc. Disord., 11, 78, 10.1097/00002093-199706000-00004 · DOI · Paper page
  37. Skoog, 1998, A population study on blood–brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia, Neurology, 50, 966, 10.1212/WNL.50.4.966 · DOI · Paper page
  38. Blennow, 1990, Blood–brain barrier disturbance in patients with Alzheimer's disease is related to vascular factors, Acta Neurol. Scand., 81, 323, 10.1111/j.1600-0404.1990.tb01563.x · DOI · Paper page
  39. Caserta, 1998, Blood–brain barrier integrity in Alzheimer's disease patients and elderly control subjects, J. Neuropsychiatry Clin. Neurosci., 10, 78, 10.1176/jnp.10.1.78 · DOI · Paper page
  40. Dysken, 1990, Rapid dynamic CT scanning in primary degenerative dementia and age-matched controls, Biol. Psychiatry, 28, 425, 10.1016/0006-3223(90)90410-4 · DOI
  41. Schlageter, 1987, Examination of blood–brain barrier permeability in dementia of the Alzheimer type with [68Ga]EDTA and positron emission tomography, J. Cereb. Blood Flow Metab., 7, 1, 10.1038/jcbfm.1987.1 · DOI · Paper page
  42. Bronge, 2000, White matter lesions in dementia: an MRI study on blood–brain barrier dysfunction, Dement. Geriatr. Cogn. Disord., 11, 263, 10.1159/000017248 · DOI · Paper page
  43. Kumar-Singh, 2005, Dense-core plaques in Tg2576 and PSAPP mouse models of Alzheimer's disease are centered on vessel walls, Am. J. Pathol., 167, 527, 10.1016/S0002-9440(10)62995-1 · DOI · Paper page
  44. Stalder, 2005, Invasion of hematopoietic cells into the brain of amyloid precursor protein transgenic mice, J. Neurosci., 25, 11125, 10.1523/JNEUROSCI.2545-05.2005 · DOI · Paper page
  45. Lebson, 2010, Trafficking CD11b-positive blood cells deliver therapeutic genes to the brain of amyloid-depositing transgenic mice, J. Neurosci., 30, 9651, 10.1523/JNEUROSCI.0329-10.2010 · DOI · Paper page
  46. Simard, 2006, Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease, Neuron, 49, 489, 10.1016/j.neuron.2006.01.022 · DOI · Paper page

Cited by

See all 55

Metadata

Authors
Meyer-Luehmann, M., & Prinz, M.
Venue
Trends in Neurosciences
Publisher
Elsevier BV
Published
2015-10
Volume
38
Issue
10
Pages
659-668
ISSN
0166-2236
Cited by
55
References
68
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Myeloid cells in Alzheimer’s disease: culprits, victims or innocent bystanders? https://app.cochat.ai/papers/10.1016/j.tins.2015.08.011
The paper
Meyer-Luehmann, M., & Prinz, M. (2015). Myeloid cells in Alzheimer’s disease: culprits, victims or innocent bystanders? Trends in Neurosciences. https://doi.org/10.1016/j.tins.2015.08.011

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.